Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.
about
The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisThrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysisScreening and surveillance for hepatocellular carcinoma: perspective of a new era?Hepatocellular carcinoma: early-stage management challengesLarge variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analysesSignificance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical TreatmentSurveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversiesHepatocellular carcinoma and cholangiocarcinoma: an update.Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue.Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study.Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis.Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study.Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach.Adequate interval for hepatocellular carcinoma surveillance.The preoperative globulin-to-albumin ratio, a novel inflammation-based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma.Hepatocellular carcinoma
P2860
Q26786170-9C7E8528-0FEC-4482-906A-AFAB5168C0FAQ26998730-5D76049C-B77D-406E-B1E8-CDA7E5DE1CFFQ30244651-8B6F9845-BA6F-4BEF-905A-7363BD9637E8Q33881131-D3BFD25E-F69D-494D-AE8E-03A2330852B9Q34203972-4731171C-B2A3-47AC-817B-75007F76C75EQ35594262-29037A36-3F59-4237-AC4D-DFAFC7092763Q35867676-F3C0289F-3CA4-4E39-BFAA-CBB3FC265808Q37266376-9899E9C3-5388-434B-88AF-D5C2335D0A92Q38163597-8B4A10DC-3EC2-4C6C-8543-168B1E9532C0Q38611765-23891468-FD87-40E7-A20E-9CBFF849D7E1Q40147468-D29E4983-4D24-4B9B-8CF9-9AC76A23412AQ40985953-E82E103A-856C-4220-A190-6CB2F09FE2DCQ41491039-1F7094B3-8BD1-4B5D-BB18-AE265D3FA73DQ42228465-26F6A850-7E48-459D-AA7D-346B824A55FAQ45788894-92E57DC5-B91A-49F9-9453-3165658C2613Q48157080-52A20C81-CA0D-4467-8431-705E0E96A3B6Q57756376-A4527C9E-EB33-4CB6-A108-A6386017F232
P2860
Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hepatocellular carcinoma surve ...... randomized study in community.
@ast
Hepatocellular carcinoma surve ...... randomized study in community.
@en
type
label
Hepatocellular carcinoma surve ...... randomized study in community.
@ast
Hepatocellular carcinoma surve ...... randomized study in community.
@en
prefLabel
Hepatocellular carcinoma surve ...... randomized study in community.
@ast
Hepatocellular carcinoma surve ...... randomized study in community.
@en
P2093
P2860
P356
P1476
Hepatocellular carcinoma surve ...... randomized study in community.
@en
P2093
Chao-Hung Hung
Chien-Hung Chen
Jing-Houng Wang
Kuo-Chin Chang
Kwong-Ming Kee
Lin-San Tsai
Ming-Chao Tsai
Pao-Fei Chen
Po-Lin Tseng
Sheng-Che Lin
P2860
P2888
P304
P356
10.1038/AJG.2012.445
P407
P577
2013-01-15T00:00:00Z
P6179
1039729635